Jie Fang

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy #

Daniel J. Tenney, Ronald E. Rose, Carl J. Baldick et al. · Hepatology · 2009 · 816 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Entecavir resistance is rare in nucleoside naïve patients with hepatitis B

Richard J. Colonno, Ronald E. Rose, Carl J. Baldick et al. · Hepatology · 2006 · 348 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Two-Year Assessment of Entecavir Resistance in Lamivudine-Refractory Hepatitis B Virus Patients Reveals Different Clinical Outcomes Depending on the Resistance Substitutions Present

Daniel J. Tenney, Ronald E. Rose, Carl J. Baldick et al. · Antimicrobial Agents and Chemotherapy · 2006 · 239 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Characterization of the Azinomycin B Biosynthetic Gene Cluster Revealing a Different Iterative Type I Polyketide Synthase for Naphthoate Biosynthesis

Qunfei Zhao, Qingli He, Wei Ding et al. · Chemistry & Biology · 2008 · 114 citations · Full text

Pharmacy, Biotechnology, Molecular Genetics +15

Cloning and Characterization of the Tetrocarcin A Gene Cluster from <i>Micromonospora chalcea</i> NRRL 11289 Reveals a Highly Conserved Strategy for Tetronate Biosynthesis in Spirotetronate Antibiotics

Jie Fang, Yiping Zhang, Lijuan Huang et al. · Journal of Bacteriology · 2008 · 92 citations · Full text

Life Sciences, Microbiology, Molecular Biology +15